EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Measles vaccination and reduced child mortality: Prevention of immune amnesia or beneficial non-specific effects of measles vaccine?

Christine S Benn, Peter Aaby

Journal of Infection · 2023

DOI: 10.1016/j.jinf.2023.07.010 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Infection, 2023. Verfasst von Christine S Benn und 1 weiteren Autor:innen. Beteiligte Einrichtung: Bandim Health Project, Indepth Network, Apartado 861, Bissau, Guinea-Bissau; Bandim Health Project, OPEN, Department of Clinical Research, University…. Hauptthemen laut MEDLINE: Measles Vaccine, Measles. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 94 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Measles vaccine (MV) has been observed to reduce all-cause mortality more than explained by prevention of measles infection. Recently, prevention of "measles-induced immune amnesia" (MIA) has been proposed as an explanation for this larger-than-anticipated beneficial effect of measles vaccine (MV). According to the "MIA hypothesis", immune amnesia leads to excess non-measles morbidity and mortality, that may last up to five years after measles infection, but may be prevented by MV. However, the benefits of MV-vaccinated children could also be due to beneficial non-specific effects (NSEs) of MV, reducing the risk of non-measles infections (The "NSE hypothesis"). The epidemiological studies do provide some support for MIA, as exposure to measles infection before 6 months of age causes long-term MIA, and over 6 months of age for 2-3 months. However, in children over 6 months of age, the MIA hypothesis is contradicted by several epidemiological patterns: First, in community studies that adjusted for MV status, children surviving acute measles infection had lower mortality than uninfected controls (44%(95%CI: 0-69%)). Second, in six randomised trials and six observational studies comparing MV-vaccinated and MV-unvaccinated children, the benefit of MV changed minimally from 54%(43-63%) to 49%(37-59%) when measles cases were censored in the survival analysis, making it unlikely that prevention of measles and its long-term consequences explained much of the reduced mortality. Third, several studies conducted in measles-free contexts still showed significantly lower mortality after MV (55%(40-67%)). Fourth, administration of MV in the presence of maternal measles antibody (MatAb) is associated with much stronger beneficial effect for child survival than administration of MV in the absence of MatAb (55%(35-68%) lower mortality). The MIA hypothesis alone cannot explain the strongly beneficial effects of MV on child survival. Conversely, the hypothesis that MV has beneficial non-specific immune training effects is compatible with all available data. Consideration should be given to continuing MV even when measles has been eradicated.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Measles VaccineMeaslesChildHumansInfantChild MortalityVaccinationSurvival AnalysisAntibodies, Viral

Stichwörter der Autor:innen

Child survivalMeasles immune amnesiaMeasles infectionMeasles vaccinationNon-specific effects of vaccines

Substanzen

Measles VaccineAntibodies, Viral

Autor:innen und Institutionen

  • Bandim Health Project, Indepth Network, Apartado 861, Bissau, Guinea-Bissau; Bandim Health Project, OPEN, Department of Clinical Research, University of Southern Denmark/Odense University Hospital, Denmark; Danish Insti…
  • Bandim Health Project, Indepth Network, Apartado 861, Bissau, Guinea-Bissau; Bandim Health Project, OPEN, Department of Clinical Research, University of Southern Denmark/Odense University Hospital, Denmark. Electronic a…

Zitieren

APA

Benn, C. S., & Aaby, P. (2023). Measles vaccination and reduced child mortality: Prevention of immune amnesia or beneficial non-specific effects of measles vaccine?. Journal of Infection. https://doi.org/10.1016/j.jinf.2023.07.010

Vancouver

Benn CS, Aaby P. Measles vaccination and reduced child mortality: Prevention of immune amnesia or beneficial non-specific effects of measles vaccine?. Journal of Infection. 2023. doi:10.1016/j.jinf.2023.07.010

BibTeX
@article{Benn2023,
  author = {Benn, Christine S and Aaby, Peter},
  title = {Measles vaccination and reduced child mortality: Prevention of immune amnesia or beneficial non-specific effects of measles vaccine?},
  journal = {Journal of Infection},
  year = {2023},
  doi = {10.1016/j.jinf.2023.07.010}
}
Kostenlos starten →